Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medical backgrounders: glaucoma.

Felipe A Medeiros1, Robert N Weinreb

  • 1Hamilton Glaucoma Center, Department of Ophthalmology, University of California, San Diego, La Jolla 92093-0946, USA.

Drugs of Today (Barcelona, Spain : 1998)
|February 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data Volume and the Need for Clinical Decision Support in Glaucoma Care.

Ophthalmology science·2026
Same author

Extraction of Glaucoma Diagnosis, Type, and Severity from Clinical Notes using Secure Cloud-based Large Language Models.

medRxiv : the preprint server for health sciences·2026
Same author

GLLaucoMed: A Secure LLM-Powered Agentic Workflow for Automated Medication Extraction from Free-Text Glaucoma Clinical Notes.

medRxiv : the preprint server for health sciences·2026
Same author

Optic Disc Fundus Images Retain Biometric Identity Signals Under Deep Learning.

Research square·2026
Same author

Development and Pilot Testing of a Mobile App Psychosocial Intervention for Psychological Distress in Individuals with Glaucoma.

medRxiv : the preprint server for health sciences·2026
Same author

Reply to Comment on "RNFL Thickness in a Population-Based Cohort: The Canadian Longitudinal Study on Aging M2M (Machine-to-Machine) Study".

American journal of ophthalmology·2026

Glaucoma, a leading cause of irreversible blindness, involves optic nerve damage and vision loss. Management focuses on lowering intraocular pressure (IOP) through medications, laser therapy, or surgery to prevent further damage.

Area of Science:

  • Ophthalmology
  • Neurology

Background:

  • Glaucoma is a primary cause of irreversible blindness globally.
  • It is characterized by progressive optic neuropathy, optic disc damage, and visual function loss.
  • Elevated intraocular pressure (IOP) is a key risk factor, though not universally present in all patients.

Purpose of the Study:

  • To review the diagnosis, risk factors, and management of glaucoma.
  • To highlight advancements in early glaucoma detection technologies.
  • To discuss current and emerging therapeutic strategies for glaucoma.

Main Methods:

  • Ophthalmoscopic examination for optic disc changes (cupping, rim thinning, hemorrhages).
  • Standard automated perimetry for visual field loss assessment.
  • Advanced functional (SWAP, FD) and structural (SST, OCT, SLP) imaging technologies for early detection.

Related Experiment Videos

Main Results:

  • Glaucomatous visual field defects typically begin peripherally and progress centrally.
  • Significant nerve fiber loss (up to 50%) can occur before detection by standard perimetry.
  • Newer technologies offer more sensitive methods for early glaucoma diagnosis.

Conclusions:

  • Glaucoma management primarily involves lowering IOP to prevent optic nerve damage.
  • Treatment options include medications (five major classes), laser trabeculoplasty, and incisional surgery.
  • Neuroprotective agents are under investigation as a future therapeutic approach.